# Maternal Hyperoxygenation in Congenital Heart Disease

> **NCT03136835** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 25 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome

## Interventions

- **DRUG:** Maternal Hyperoxygenation

## Key facts

- **NCT ID:** NCT03136835
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-02
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136835, "Maternal Hyperoxygenation in Congenital Heart Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03136835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*